3 completed, 2 recruiting. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Uterine Serous Carcinoma: new trials by email Literature Review of Uterine Serous Carcinoma trials Research Report on Uterine Serous Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azenosertib in Uterine Serous Carcinoma: Biomarker Study Azenosertib - Uterine Serous Carcinoma, Uterine Carcinoma | Phase 2 | Recruiting | Joyce Liu, MD | 25 | 2025-03-05 | 2026-03-02 |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer VLS-1488 - Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary | Phase 1 / Phase 2 | Recruiting | Volastra Therapeutics, Inc. | 200 | 2023-10-18 | 2025-11-04 |
| A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma Azenosertib - Uterine Serous Carcinoma | Phase 2 | Completed | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 92 | 2021-07-28 | 2026-03-18 |
| A Study of Adavosertib as Treatment for Uterine Serous Carcinoma Adavosertib - Uterine Serous Carcinoma | Phase 2 | Completed | AstraZeneca | 109 | 2020-11-30 | 2023-08-14 |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma Niraparib - Endometrial Cancer, Papillary Serous Endometrial Carcinoma | Phase 2 | Completed | Northwell Health | 22 | 2019-12-30 | 2025-08-19 |
Endometrial Neoplasms (2) · Uterine Neoplasms (2) · Chromosomal Instability (1) · Cystadenocarcinoma, Serous (1) · Squamous Cell Carcinoma of Head and Neck (1) · Triple Negative Breast Neoplasms (1)
Neoplasms (4) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Diseases (3) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Adenocarcinoma (1) · Breast Diseases (1)
adavosertib (1) · niraparib (1)
AstraZeneca (1) · Joyce Liu, MD (1) · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc (1) · Northwell Health (1) · Volastra Therapeutics, Inc. (1)
United States (5) · Canada (2) · Australia (1) · France (1) · Georgia (1) · Italy (1) · Spain (1)
Joyce Liu, MD, MPH (2) · Marina Frimer, MD (1)